Dermatology CRO Market
Dermatology CRO Market Analysis by Type (Drug Discovery, Clinical, Preclinical), by Service (Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/Assurance, Bio-statistics), by Region - Global Forecast 2022-3032
Analysis of Dermatology CRO market covering 30+ countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Dermatology CRO Market Growth Overview for 2022 to 2032
The Dermatology CRO Market size was valued at US$ 4.0 Billion in 2021, and is projected to reach US$ 12.8 Billion by 2032, with a projected compound annual growth rate (CAGR) of 9.1% during the forecast period from 2023 to 2032.
Global market is segmented into various sub-types, including drug discovery, clinical, preclinical. Among all the types, Clinical type dermatology CRO is expected to be the highest revenue grossing service, accounting for an absolute dollar opportunity of nearly US$ 3.5 Billion during 2022 – 2032.
Revenue of Dermatology CRO from 2017 to 2021 Compared to Demand Outlook for 2021 to 2031
As per the Dermatology CRO industry research by Fact.MR - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the Dermatology CRO industry increased at around 7.8% CAGR, wherein, countries such as the U.S., U.K., China, Japan and South Korea held significant share in the global market.
The rising need for topical dermatological drugs to treat acne, such as anti-inflammatory, anti-infective, local anaesthetics, cleansers, and emollients, is a primary driver of the market. Increased awareness of skin disorders, a high need for quick detection, and a growth in the frequency of skin cancer and other skin ailments are all propelling the business ahead. Owing to this, Dermatology CRO market is projected to grow at a CAGR of 9.1% over the coming 10 years.
- The Dermatology CRO market is estimated to reach a valuation of US$ 1.7 Bn in 2022 as the worldwide revenues was up by 8.6% year-over-year. Because of the introduction of virtual clinical trials and government measures to maintain the disrupted supply chains in healthcare, the market for dermatological contract research organisations (CRO) was mostly unscathed by the COVID 19’s ramifications. Fact.MR estimates that Dermatology CRO revenue will grow 2.4X from 2022 to 2032, reaching nearly US$ 4.3 Bn in 2032.
- The revenue through clinical dermatology type is projected to garner a CAGR of around 10% during 2022 – 2032.
- Dermatology CRO revenue through clinical monitoring will account for majority share, owing to countries’ focus on dermatological medications.
What is Making Dermatology CRO an Essential Component?
The market is primarily driven by the need for topical dermatological medications such as anti-infectives, anti-inflammatory, local anesthetics, emollients, and cleansers to cure acne. Over the forecast period, increased incidences of skin diseases over the world are expected to boost dermatology CRO market growth.
Acne is the most prevalent skin disease in the United States, with up to 50 Mn people affected each year, according to the American Academy of Dermatology Association. One out of every ten people suffers with atopic dermatitis at some time in their lives. In the United States, 7.5 Mn individuals suffer with psoriasis. Rosacea is a common skin ailment affecting 16 million individuals in the United States. More than 9,500 people in the United States were diagnosed with skin cancer every day.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Region is projected to Offer the Largest Opportunity for Dermatology CRO?
With over 10.4% projected growth rate, Dermatology CRO revenue is expected to grow at fastest pace in North America, during 2022 - 2032. This is due to a number of factors, including an aging population, increased awareness of skin conditions, and the development of new treatments. The CRO industry is growing rapidly, and the dermatology segment is expected to experience strong growth in the next few years.
Country-wise Analysis
Which Country Lies at the Centerstage for Dermatology CRO Revenue?
US leads the global revenues of Dermatology CRO market. This is attributed to the high frequency of skin problems, demographic variety, ease of recruiting and retaining patients, and an improved regulatory environment. Furthermore, market development is aided by favourable government initiatives. In February 2018, the Central Drugs Standard Control Organization (CDSCO) published new standards that are intended to reduce the time it takes to gain clearance from almost 30 to 60 days.
North America grabbed a highest dermatology CRO market share in 2021 due to the largest number of trials done and outsourced in the region. The increased government support for R&D activities through grants and money to research institutes and enterprises has further supported the expansion of this regional industry. In 2018, the US government, for example, spent US$ 194.2 Bn on medical and health research and development.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Why Clinical Dermatology CRO Remains the Faster Revenue Generating Segment?
Clinical dermatology CRO is the fastest revenue generating segment because it offers a wide range of services that can be customized to meet the specific needs of each client. This allows for quick turnaround times and efficient project management, which results in increased profits for the client. Additionally, the dermatology market is growing rapidly, providing opportunities for continued growth and expansion. Increasing prevalence of skin diseases, especially in case of psoriasis, is expected to propel clinical dermatology CRO segment.
How Has COVID-19 Impacted Revenue Generation from Dermatology CRO?
The necessity of virtual trials and the utilisation of technology and software solutions has been underlined by the COVID-19 pandemic. The increased use of machine learning-based platforms, artificial intelligence, and creative trial designs is projected to change the dermatological CRO landscape in the next years. Biopharmaceutical and pharmaceutical investments in innovative and revolutionary therapies, such as regenerative medicine, and drug development services, are driving R&D activities. Experts and skills in a range of therapeutic disciplines are still needed by sponsors.
The impact of COVID-19 on Dermatology CRO was largely observed through the growing awareness of skin disorders, a high need for speedy diagnosis, and an increase in the frequency of skin cancer and other skin maladies.
Competitive Analysis
According to the market research analysis, partnerships and expansion have been the prominent development in Dermatology CRO market in recent years. IQVIA HOLDINGS INC., Covance Inc., Pharmaceutical Product Development, LLC (PPD), Parexel International Corporation, Charles River Laboratories International, Inc., Icon, Plc, Medidata Solutions, Inc., Syneos Health, Pharmaron, GVK Biosciences Private Limited, Wuxi AppTec, MEDPACE HOLDINGS, INC., PRA Health Sciences, CTI Clinical Trial & Consulting, Bioskin, Proinnovera, Biorasi, Javara, TFS are the prominent providers of Dermatology CRO services.
Some of the recent developments of key Dermatology CRO providers are as follows:
- In 2021 Thermo Fisher signed a binding deal to buy PPD for US$ 17.4 Bn. This purchase will greatly strengthen Thermo Fisher's position in the clinical research services market, particularly in the early phase clinical trials business. In addition to strengthening their services, healthcare contract research businesses are aiming to provide their services on a worldwide basis.
- In February 2021, Icon plc signed a binding deal to buy PRA Health Sciences for a valuation of around US$ 12 Bn. Customers will benefit from the merged firm because of the enhanced geographic, functional, and therapeutic scale.
- In October 2019, Parexel strengthened its ties with the Society for Clinical Research Sites (SCRS), to safeguard the interests of clinical research sites. The company implemented many significant initiatives as a Site Engagement Partner targeted at enhancing the patient experience in clinical trials.
Similarly, recent developments related to companies offering Dermatology CRO have been tracked by the team at Fact.MR, which are available in the full report.
Dermatology CRO Market Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2017-2021 |
|
Market Analysis |
US$ Bn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Market Segments Covered in Dermatology CRO Industry Analysis
-
By Type :
- Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Preclinical
- Drug Discovery
-
By Service :
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient and Site Recruitment
- Technology
- Other Services
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Fact.MR Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Dermatology CRO Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Global Dermatology CRO Market (US$ Mn) 4.2. Dermatology CRO Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Dermatology CRO Market Growth 4.5.3. Dermatology CRO Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Dermatology CRO Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Dermatology CRO Market Demand Analysis 2017-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2017-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Dermatology CRO Market Value Analysis 2017-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032, By Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Type, 2017-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032 8.3.1. Drug Discovery 8.3.1.1. Target Validation 8.3.1.2. Lead Identification 8.3.1.3. Lead Optimization 8.3.2. Clinical 8.3.2.1. Phase I 8.3.2.2. Phase II 8.3.2.3. Phase III 8.3.2.4. Phase IV 8.3.3. Pre-clinical 8.4. Market Attractiveness Analysis By Type 9. Global Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032, By Service 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Service, 2017-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Service, 2022-2032 9.3.1. Project Management/Clinical Supply Management 9.3.2. Data Management 9.3.3. Regulatory/Medical Affairs 9.3.4. Medical Writing 9.3.5. Clinical Monitoring 9.3.6. Quality Management/Assurance 9.3.7. Bio-statistics 9.3.8. Investigator Payments 9.3.9. Laboratory 9.3.10. Patient and Site Recruitment 9.3.11. Technology 9.3.12. Other Services 9.4. Market Attractiveness Analysis By Service 10. Global Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032, By Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 11.4.1. By Country 11.4.1.1. U.S. 11.4.1.2. Canada 11.4.1.3. Rest of North America 11.4.2. By Type 11.4.3. By Service 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Type 11.5.3. By Service 12. Latin America Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. Brazil 12.4.1.2. Mexico 12.4.1.3. Rest of Latin America 12.4.2. By Type 12.4.3. By Service 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Type 12.5.3. By Service 13. Europe Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. Germany 13.4.1.2. France 13.4.1.3. U.K. 13.4.1.4. Italy 13.4.1.5. Benelux 13.4.1.6. Nordic Countries 13.4.1.7. Rest of Europe 13.4.2. By Type 13.4.3. By Service 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Type 13.5.3. By Service 14. Asia Pacific Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. China 14.4.1.2. Japan 14.4.1.3. South Korea 14.4.1.4. Rest of Asia Pacific 14.4.2. By Type 14.4.3. By Service 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Type 14.5.3. By Service 15. Middle East and Africa Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. GCC Countries 15.4.1.2. South Africa 15.4.1.3. Turkey 15.4.1.4. Rest of Middle East and Africa 15.4.2. By Type 15.4.3. By Service 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Type 15.5.3. By Service 16. Key Countries Dermatology CRO Market Analysis 2017-2021 and Forecast 2022-2032 16.1. Introduction 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Dermatology CRO Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.2.2.1. By Type 16.2.2.2. By Service 16.3. Canada Dermatology CRO Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.3.2.1. By Type 16.3.2.2. By Service 16.4. Mexico Dermatology CRO Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.4.2.1. By Type 16.4.2.2. By Service 16.5. Brazil Dermatology CRO Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.5.2.1. By Type 16.5.2.2. By Service 16.6. Germany Dermatology CRO Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.6.2.1. By Type 16.6.2.2. By Service 16.7. France Dermatology CRO Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.7.2.1. By Type 16.7.2.2. By Service 16.8. Italy Dermatology CRO Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.8.2.1. By Type 16.8.2.2. By Service 16.9. BENELUX Dermatology CRO Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.9.2.1. By Type 16.9.2.2. By Service 16.10. UK Dermatology CRO Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.10.2.1. By Type 16.10.2.2. By Service 16.11. Nordic Countries Dermatology CRO Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.11.2.1. By Type 16.11.2.2. By Service 16.12. China Dermatology CRO Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.12.2.1. By Type 16.12.2.2. By Service 16.13. Japan Dermatology CRO Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.13.2.1. By Type 16.13.2.2. By Service 16.14. South Korea Dermatology CRO Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.14.2.1. By Type 16.14.2.2. By Service 16.15. GCC Countries Dermatology CRO Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.15.2.1. By Type 16.15.2.2. By Service 16.16. South Africa Dermatology CRO Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.16.2.1. By Type 16.16.2.2. By Service 16.17. Turkey Dermatology CRO Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.17.2.1. By Type 16.17.2.2. By Service 16.17.3. Competition Landscape and Player Concentration in the Country 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 17.4.1. By Regional footprint of Players 17.4.2. Product footprint by Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive 18.3.1. IQVIA HOLDINGS INC. 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Sales Footprint 18.3.1.4. Strategy Overview 18.3.2. Covance Inc 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Sales Footprint 18.3.2.4. Strategy Overview 18.3.3. Pharmaceutical Product Development, LLC 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Sales Footprint 18.3.3.4. Strategy Overview 18.3.4. Parexel International Corporation 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Sales Footprint 18.3.4.4. Strategy Overview 18.3.5. Charles River Laboratories International, Inc. 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Sales Footprint 18.3.5.4. Strategy Overview 18.3.6. Icon, Plc 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Sales Footprint 18.3.6.4. Strategy Overview 18.3.7. Medidata Solutions, Inc. 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Sales Footprint 18.3.7.4. Strategy Overview 18.3.8. Syneos Health 18.3.8.1. Overview 18.3.8.2. Product Portfolio 18.3.8.3. Sales Footprint 18.3.8.4. Strategy Overview 18.3.9. Pharmaron 18.3.9.1. Overview 18.3.9.2. Product Portfolio 18.3.9.3. Sales Footprint 18.3.9.4. Strategy Overview 18.3.10. GVK Biosciences Private Limited 18.3.10.1. Overview 18.3.10.2. Product Portfolio 18.3.10.3. Sales Footprint 18.3.10.4. Strategy Overview 18.3.11. Wuxi AppTec 18.3.11.1. Overview 18.3.11.2. Product Portfolio 18.3.11.3. Sales Footprint 18.3.11.4. Strategy Overview 18.3.12. MEDPACE HOLDINGS, INC. 18.3.12.1. Overview 18.3.12.2. Product Portfolio 18.3.12.3. Sales Footprint 18.3.12.4. Strategy Overview 18.3.13. PRA Health Sciences 18.3.13.1. Overview 18.3.13.2. Product Portfolio 18.3.13.3. Sales Footprint 18.3.13.4. Strategy Overview 18.3.14. CTI Clinical Trial & Consulting 18.3.14.1. Overview 18.3.14.2. Product Portfolio 18.3.14.3. Sales Footprint 18.3.14.4. Strategy Overview 18.3.15. Bioskin 18.3.15.1. Overview 18.3.15.2. Product Portfolio 18.3.15.3. Sales Footprint 18.3.15.4. Strategy Overview 18.3.16. Proinnovera 18.3.16.1. Overview 18.3.16.2. Product Portfolio 18.3.16.3. Sales Footprint 18.3.16.4. Strategy Overview 18.3.17. Biorasi 18.3.17.1. Overview 18.3.17.2. Product Portfolio 18.3.17.3. Sales Footprint 18.3.17.4. Strategy Overview 18.3.18. Javara 18.3.18.1. Overview 18.3.18.2. Product Portfolio 18.3.18.3. Sales Footprint 18.3.18.4. Strategy Overview 18.3.19. TFS 18.3.19.1. Overview 18.3.19.2. Product Portfolio 18.3.19.3. Sales Footprint 18.3.19.4. Strategy Overview 19. Assumptions and Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Dermatology CRO Market Value (US$ Mn), By Type, 2017 – 2021
Table 2: Global Dermatology CRO Market Value (US$ Mn), By Type, 2022 – 2032
Table 3: Global Dermatology CRO Market Value (US$ Mn), By Service, 2017 – 2021
Table 4: Global Dermatology CRO Market Value (US$ Mn), By Service, 2022 – 2032
Table 5: Global Dermatology CRO Market, By Region, 2017 – 2021
Table 6: Global Dermatology CRO Market, By Region, 2022 – 2032
Table 7: North America Dermatology CRO Market Value (US$ Mn), By Type, 2017 – 2021
Table 8: North America Dermatology CRO Market Value (US$ Mn), By Type, 2022 – 2032
Table 9: North America Dermatology CRO Market Value (US$ Mn), By Service, 2017 – 2021
Table 10: North America Dermatology CRO Market Value (US$ Mn), By Service, 2022 – 2032
Table 11: North America Dermatology CRO Market, By Country, 2017 – 2021
Table 12: North America Dermatology CRO Market, By Country, 2022 – 2032
Table 13: Latin America Dermatology CRO Market Value (US$ Mn), By Type, 2017 – 2021
Table 14: Latin America Dermatology CRO Market Value (US$ Mn), By Type, 2022 – 2032
Table 15: Latin America Dermatology CRO Market Value (US$ Mn), By Service, 2017 – 2021
Table 16: Latin America Dermatology CRO Market Value (US$ Mn), By Service, 2022 – 2032
Table 17: Latin America Dermatology CRO Market, By Country, 2017 – 2021
Table 18: Latin America Dermatology CRO Market, By Country, 2022 – 2032
Table 19: Europe Dermatology CRO Market Value (US$ Mn), By Type, 2017 – 2021
Table 20: Europe Dermatology CRO Market Value (US$ Mn), By Type, 2022 – 2032
Table 21: Europe Dermatology CRO Market Value (US$ Mn), By Service, 2017 – 2021
Table 22: Europe Dermatology CRO Market Value (US$ Mn), By Service, 2022 – 2032
Table 23: Europe Dermatology CRO Market, By Country, 2017 – 2021
Table 24: Europe Dermatology CRO Market, By Country, 2022 – 2032
Table 25: Asia Pacific Dermatology CRO Market Value (US$ Mn), By Type, 2017 – 2021
Table 26: Asia Pacific Dermatology CRO Market Value (US$ Mn), By Type, 2022 – 2032
Table 27: Asia Pacific Dermatology CRO Market Value (US$ Mn), By Service, 2017 – 2021
Table 28: Asia Pacific Dermatology CRO Market Value (US$ Mn), By Service, 2022 – 2032
Table 29: Asia Pacific Dermatology CRO Market, By Country, 2017 – 2021
Table 30: Asia Pacific Dermatology CRO Market, By Country, 2022 – 2032
Table 31: MEA Dermatology CRO Market Value (US$ Mn), By Type, 2017 – 2021
Table 32: MEA Dermatology CRO Market Value (US$ Mn), By Type, 2022 – 2032
Table 33: MEA Dermatology CRO Market Value (US$ Mn), By Service, 2017 – 2021
Table 34: MEA Dermatology CRO Market Value (US$ Mn), By Service, 2022 – 2032
Table 35: MEA Dermatology CRO Market, By Country, 2017 – 2021
Table 36: MEA Dermatology CRO Market, By Country, 2022 – 2032
Table 37: Global Dermatology CRO Market Incremental $ Opportunity, By Type, 2017 - 2021
Table 38: Global Dermatology CRO Market Incremental $ Opportunity, By Service, 2022 – 2032
Table 39: Global Dermatology CRO Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 40: North America Dermatology CRO Market Incremental $ Opportunity, By Type, 2017 - 2021
Table 41: North America Dermatology CRO Market Incremental $ Opportunity, By Service, 2022 – 2032
Table 42: North America Dermatology CRO Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 43: Latin America Dermatology CRO Market Incremental $ Opportunity, By Type, 2017 - 2021
Table 44: Latin America Dermatology CRO Market Incremental $ Opportunity, By Service, 2022 – 2032
Table 45: Latin America Dermatology CRO Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 46: Europe Dermatology CRO Market Incremental $ Opportunity, By Type, 2017 - 2021
Table 47: Europe Dermatology CRO Market Incremental $ Opportunity, By Service, 2022 – 2032
Table 48: Europe Dermatology CRO Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 49: Asia Pacific Dermatology CRO Market Incremental $ Opportunity, By Type, 2017 - 2021
Table 50: Asia Pacific Dermatology CRO Market Incremental $ Opportunity, By Service, 2022 – 2032
Table 51: Asia Pacific Dermatology CRO Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 52: MEA Dermatology CRO Market Incremental $ Opportunity, By Type, 2017 - 2021
Table 53: MEA Dermatology CRO Market Incremental $ Opportunity, By Service, 2022 – 2032
Table 54: MEA Dermatology CRO Market Incremental $ Opportunity, By Country, 2022 - 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Dermatology CRO Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 2: Global Dermatology CRO Market Absolute $ Historical Gain (2017 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Dermatology CRO Market Share, By Type, 2022 & 2032
Figure 4: Global Dermatology CRO Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 5: Global Dermatology CRO Market Attractiveness Index, By Type – 2022-2032
Figure 6: Global Dermatology CRO Market Share, By Service, 2022 & 2032
Figure 7: Global Dermatology CRO Market Y-o-Y Growth Projections, By Service – 2022-2032
Figure 8: Global Dermatology CRO Market Attractiveness Index, By Service – 2022-2032
Figure 9: Global Dermatology CRO Market Share, By Region, 2022 & 2032
Figure 10: Global Dermatology CRO Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 11: Global Dermatology CRO Market Attractiveness Index, By Region – 2022-2032
Figure 12: North America Dermatology CRO Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 13: North America Dermatology CRO Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 14: North America Dermatology CRO Market Share, By Type, 2022 & 2032
Figure 15: North America Dermatology CRO Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 16: North America Dermatology CRO Market Attractiveness Index, By Type – 2022-2032
Figure 17: North America Dermatology CRO Market Share, By Service, 2022 & 2032
Figure 18: North America Dermatology CRO Market Y-o-Y Growth Projections, By Service – 2022-2032
Figure 19: North America Dermatology CRO Market Attractiveness Index, By Service – 2022-2032
Figure 20: North America Dermatology CRO Market Share, By Country, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 22: North America Market Attractiveness Index, By Country – 2022-2032
Figure 23: Latin America Dermatology CRO Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 24: Latin America Dermatology CRO Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 25: Latin America Dermatology CRO Market Share, By Type, 2022 & 2032
Figure 26: Latin America Dermatology CRO Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 27: Latin America Dermatology CRO Market Attractiveness Index, By Type – 2022-2032
Figure 28: Latin America Dermatology CRO Market Share, By Service, 2022 & 2032
Figure 29: Latin America Dermatology CRO Market Y-o-Y Growth Projections, By Service – 2022-2032
Figure 30: Latin America Dermatology CRO Market Attractiveness Index, By Service – 2022-2032
Figure 31: Latin America Dermatology CRO Market Share, By Country, 2022 & 2032
Figure 32: Latin America Dermatology CRO Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 33: Latin America Dermatology CRO Market Attractiveness Index, By Country – 2022-2032
Figure 34: Europe Dermatology CRO Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 35: Europe Dermatology CRO Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 36: Europe Dermatology CRO Market Share, By Type, 2022 & 2032
Figure 37: Europe Dermatology CRO Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 38: Europe Dermatology CRO Market Attractiveness Index, By Type – 2022-2032
Figure 39: Europe Dermatology CRO Market Share, By Service, 2022 & 2032
Figure 40: Europe Dermatology CRO Market Y-o-Y Growth Projections, By Service – 2022-2032
Figure 41: Europe Dermatology CRO Market Attractiveness Index, By Service – 2022-2032
Figure 42: Europe Dermatology CRO Market Share, By Country, 2022 & 2032
Figure 43: Europe Dermatology CRO Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 44: Europe Dermatology CRO Market Attractiveness Index, By Country – 2022-2032
Figure 45: MEA Dermatology CRO Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 46: MEA Dermatology CRO Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 47: MEA Dermatology CRO Market Share, By Type, 2022 & 2032
Figure 48: MEA Dermatology CRO Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 49: MEA Dermatology CRO Market Attractiveness Index, By Type – 2022-2032
Figure 50: MEA Dermatology CRO Market Share, By Service, 2022 & 2032
Figure 51: MEA Dermatology CRO Market Y-o-Y Growth Projections, By Service – 2022-2032
Figure 52: MEA Dermatology CRO Market Attractiveness Index, By Service – 2022-2032
Figure 53: MEA Dermatology CRO Market Share, By Country, 2022 & 2032
Figure 54: MEA Dermatology CRO Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 55: MEA Dermatology CRO Market Attractiveness Index, By Country – 2022-2032
Figure 56: Asia Pacific Dermatology CRO Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 57: Asia Pacific Dermatology CRO Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 58: Asia Pacific Dermatology CRO Market Share, By Type, 2022 & 2032
Figure 59: Asia Pacific Dermatology CRO Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 60: Asia Pacific Dermatology CRO Market Attractiveness Index, By Type – 2022-2032
Figure 61: Asia Pacific Dermatology CRO Market Share, By Service, 2022 & 2032
Figure 62: Asia Pacific Dermatology CRO Market Y-o-Y Growth Projections, By Service – 2022-2032
Figure 63: Asia Pacific Dermatology CRO Market Attractiveness Index, By Service – 2022-2032
Figure 64: Asia Pacific Dermatology CRO Market Share, By Country, 2022 & 2032
Figure 65: Asia Pacific Dermatology CRO Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 66: Asia Pacific Dermatology CRO Market Attractiveness Index, By Country – 2022-2032
Figure 67: US Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 68: US Dermatology CRO Market Share, By Type, 2021
Figure 69: US Dermatology CRO Market Share, By Service, 2021
Figure 70: Canada Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 71: Canada Dermatology CRO Market Share, By Type, 2021
Figure 72: Canada Dermatology CRO Market Share, By Service, 2021
Figure 73: Brazil Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 74: Brazil Dermatology CRO Market Share, By Type, 2021
Figure 75: Brazil Dermatology CRO Market Share, By Service, 2021
Figure 76: Mexico Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 77: Mexico Dermatology CRO Market Share, By Type, 2021
Figure 78: Mexico Dermatology CRO Market Share, By Service, 2021
Figure 79: Germany Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 80: Germany Dermatology CRO Market Share, By Type, 2021
Figure 81: Germany Dermatology CRO Market Share, By Service, 2021
Figure 82: U.K. Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 83: U.K. Dermatology CRO Market Share, By Type, 2021
Figure 84: U.K. Dermatology CRO Market Share, By Service, 2021
Figure 85: France Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: France Dermatology CRO Market Share, By Type, 2021
Figure 87: France Dermatology CRO Market Share, By Service, 2021
Figure 88: Italy Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 89: Italy Dermatology CRO Market Share, By Type, 2021
Figure 90: Italy Dermatology CRO Market Share, By Service, 2021
Figure 91: BENELUX Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 92: BENELUX Dermatology CRO Market Share, By Type, 2021
Figure 93: BENELUX Dermatology CRO Market Share, By Service, 2021
Figure 94: Nordic Countries Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 95: Nordic Countries Dermatology CRO Market Share, By Type, 2021
Figure 96: Nordic Countries Dermatology CRO Market Share, By Service, 2021
Figure 97: China Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: China Dermatology CRO Market Share, By Type, 2021
Figure 99: China Dermatology CRO Market Share, By Service, 2021
Figure 100: Japan Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 101: Japan Dermatology CRO Market Share, By Type, 2021
Figure 102: Japan Dermatology CRO Market Share, By Service, 2021
Figure 103: South Korea Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 104: South Korea Dermatology CRO Market Share, By Type, 2021
Figure 105: South Korea Dermatology CRO Market Share, By Service, 2021
Figure 106: GCC Countries Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 107: GCC Countries Dermatology CRO Market Share, By Type, 2021
Figure 108: GCC Countries Dermatology CRO Market Share, By Service, 2021
Figure 109: South Africa Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: South Africa Dermatology CRO Market Share, By Type, 2021
Figure 111: South Africa Dermatology CRO Market Share, By Service, 2021
Figure 112: Turkey Dermatology CRO Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 113: Turkey Dermatology CRO Market Share, By Type, 2021
Figure 114: Turkey Dermatology CRO Market Share, By Service, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the current worth of the Dermatology CRO market?
The global dermatology CRO market is worth more than US$ 4 Billion at present.
What is the sales forecast for Dermatology CRO?
Value of Dermatology CRO are projected to increase at a CAGR of around 9.1% during 2022-2032.
What was the last 5 year’s market CAGR?
Value of Dermatology CRO increased at a CAGR of around 7.8% during 2017-2021.
What is a key trend shaping the growth of the market for Dermatology CRO?
One of the key trends in Dermatology CRO market includes that their providers have been expanding their geographical footprint.
What are the factors driving the revenue for Dermatology CRO market?
Growing awareness of skin disorders, a high need for speedy diagnosis, and an increase in the frequency of skin cancer and other skin maladies are propelling the dermatological CRO industry ahead.
Which are the top 5 countries driving demand for Dermatology CRO?
Top 5 countries driving demand for Dermatology CRO are the U.S., U.K., China, Japan and South Korea.
What is the outlook for the market in US?
US will accounted for over 33% of global Dermatology CRO demand in 2032 with a CAGR of 9.4%.
At what percentage is sales of Dermatology CRO going to register growth from 2022 to 2032?
The market for Dermatology CRO is projected to expand at a CAGR of around 9.1% during 2022 – 2032 with the global market size of US$ 12.8 Billion
What do statistics for South Korea and Japan reveal?
While the market in South Korea is expected to grow at nearly 8.9%, the market in Japan is projected to register a CAGR of nearly 12.5% during 2022-2032.
Dermatology CRO Market